Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer


Eroglu C., ORHAN O., Ünal D., Dogu G. G., Karaca H., Dikilitas M., ...Daha Fazla

ANNALS OF THORACIC MEDICINE, cilt.8, sa.2, ss.109-115, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 2
  • Basım Tarihi: 2013
  • Doi Numarası: 10.4103/1817-1737.109824
  • Dergi Adı: ANNALS OF THORACIC MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.109-115
  • Anahtar Kelimeler: Cisplatin, concomitant chemoradiotherapy, docetaxel, non-small cell lung cancer, CONCURRENT THORACIC RADIOTHERAPY, LEUKEMIA GROUP-B, SOUTHWEST-ONCOLOGY-GROUP, PHASE-III TRIAL, RADIATION-THERAPY, RANDOMIZED-TRIAL, STAGE IIIB, CHEMORADIATION THERAPY, PROGNOSTIC-FACTORS, COMBINATION
  • Erciyes Üniversitesi Adresli: Evet

Özet

OBJECTIVES: To evaluate treatment results and toxicities in patients who received concomitant chemoradiotherapy (CRT) followed by consolidation with docetaxel and cisplatin in locally advanced unresectable non-small cell lung cancer (NSCLC).